Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1678542
PUBLISHER: Grand View Research | PRODUCT CODE: 1678542
North America And Europe Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Pathogen, By Testing, By Method, By End Use, By Country, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
North America And Europe Sepsis Diagnostics Market Growth & Trends:
The North America and Europe sepsis diagnostics market size is anticipated to reach USD 1.24 billion by 2030 and is anticipated to expand at a CAGR of 7.3% during the forecast period, according to a new report by Grand View Research, Inc. North America experiences a significant prevalence of sepsis, making it a leading cause of hospital deaths. This high incidence drives the demand for effective diagnostic solutions. Favorable reimbursement policies also encourage healthcare providers to adopt advanced diagnostics, while increased awareness and public-private funding boost the development of innovative tools.
In Europe, stringent regulations ensure reliable sepsis testing methods are available, supporting market growth. The aging population, more susceptible to infections, further escalates the demand for tailored diagnostic solutions. In addition, the rising healthcare spending enhances access to advanced diagnostics across European countries.
The European Centre for Disease Prevention and Control (ECDC) reported in 2024 that HAIs affected around 4.5 million patients annually, with sepsis as a major consequence. In 2023, the UK government allocated approximately USD 12 million for antimicrobial resistance (AMR) research, directly aiding sepsis management initiatives. Moreover, projected federal funding for sepsis-related programs in the U.S. was expected to exceed USD 50 million in 2024, aimed at improving diagnostic technologies and reducing mortality rates associated with sepsis.
North America And Europe Sepsis Diagnostics Market Report Highlights:
- Based on product, blood culture media held over 30.0% market share in 2023, while assay kits and reagents are poised for lucrative growth from 2025 to 2030 onwards
- Microbiology led the technology segment in 2024, while molecular diagnostics are anticipated to witness the fastest rate of 9.3% over the forecast period
- Based on pathogen, bacterial sepsis held the largest market share in 2024, driven by significant mortality rates, rising HAIs, and technological advancements. It is also expected to grow at the fastest CAGR over the forecast period
- Based on testing, POC testing is expected to grow at a staggering 9.6% CAGR as laboratory testing led the testing segment
- Based on method, automated diagnostic methods are expected to grow at the fastest CAGR over the forecast period
- The U.S. dominated the North America sepsis diagnostics market as the shift to value-based care promotes early detection, while supportive reimbursement, increased awareness, and government initiatives enhance sepsis management innovations.
- The UK sepsis diagnostics market is expected to grow at the fastest rate of 8.1% over the forecast period in the Europe market
- In March 2024, BD collaborated with GOCC in Poland to enhance access to advanced bloodstream infection testing, deploying state-of-the-art microbiology equipment across over 150 hospitals and clinics for improved sepsis management
Product Code: GVR-4-68040-511-8
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Pathogen
- 1.2.4. Testing
- 1.2.5. Method
- 1.2.6. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. North America and Europe Sepsis Diagnostics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. North America and Europe Sepsis Diagnostics Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
- 4.5. Blood Culture Media
- 4.5.1. Blood Culture Media Market, 2018 - 2030 (USD Million)
- 4.6. Assay Kits and Reagents
- 4.6.1. Assay Kits and Reagents Market, 2018 - 2030 (USD Million)
- 4.7. Software
- 4.7.1. Software Market, 2018 - 2030 (USD Million)
Chapter 5. North America and Europe Sepsis Diagnostics Market: Technology Business Analysis
- 5.1. Technology Market Share, 2024 & 2030
- 5.2. Technology Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
- 5.4. Microbiology
- 5.4.1. Microbiology Market, 2018 - 2030 (USD Million)
- 5.5. Molecular Diagnostics
- 5.5.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
- 5.5.2. Polymerase Chain Reaction (PCR)
- 5.5.2.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)
- 5.5.3. DNA Microarrays
- 5.5.3.1. DNA Microarrays Market, 2018 - 2030 (USD Million)
- 5.5.4. Syndromic Panel Testing
- 5.5.4.1. Syndromic Panel Testing Market, 2018 - 2030 (USD Million)
- 5.5.5. Others
- 5.5.5.1. Others Market, 2018 - 2030 (USD Million)
- 5.6. Immunoassays
- 5.6.1. Immunoassays Market, 2018 - 2030 (USD Million)
- 5.7. Flow Cytometry
- 5.7.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. North America and Europe Sepsis Diagnostics Market: Pathogen Business Analysis
- 6.1. Pathogen Market Share, 2024 & 2030
- 6.2. Pathogen Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Pathogen, 2018 to 2030 (USD Million)
- 6.4. Bacterial Sepsis
- 6.4.1. Bacterial Sepsis Market, 2018 - 2030 (USD Million)
- 6.4.2. Gram-positive Bacteria
- 6.4.2.1. Gram-positive Bacteria Market, 2018 - 2030 (USD Million)
- 6.4.3. Gram-negative Bacteria
- 6.4.3.1. Gram-negative Bacteria Market, 2018 - 2030 (USD Million)
- 6.5. Fungal Sepsis
- 6.5.1. Fungal Sepsis Market, 2018 - 2030 (USD Million)
- 6.6. Viral Sepsis
- 6.6.1. Viral Sepsis Market, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. North America and Europe Sepsis Diagnostics Market: Testing Business Analysis
- 7.1. Testing Market Share, 2024 & 2030
- 7.2. Testing Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, by Testing, 2018 to 2030 (USD Million)
- 7.4. Laboratory Testing
- 7.4.1. Laboratory Testing Market, 2018 - 2030 (USD Million)
- 7.5. PoC Testing
- 7.5.1. PoC Testing Market, 2018 - 2030 (USD Million)
Chapter 8. North America and Europe Sepsis Diagnostics Market: Method Business Analysis
- 8.1. Method Market Share, 2024 & 2030
- 8.2. Method Segment Dashboard
- 8.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
- 8.4. Automated Diagnostics
- 8.4.1. Automated Diagnostics Market, 2018 - 2030 (USD Million)
- 8.5. Conventional Diagnostics
- 8.5.1. Conventional Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 9. North America and Europe Sepsis Diagnostics Market: End Use Business Analysis
- 9.1. End Use Market Share, 2024 & 2030
- 9.2. End Use Segment Dashboard
- 9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 9.4. Hospitals & Clinics
- 9.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
- 9.5. Pathology & Reference Laboratories
- 9.5.1. Pathology & Reference Laboratories Market, 2018 - 2030 (USD Million)
- 9.6. Research Institutes and Others
- 9.6.1. Research Institutes and Others Market, 2018 - 2030 (USD Million)
Chapter 10. North America and Europe Sepsis Diagnostics Market: Regional Estimates & Trend Analysis
- 10.1. Regional Market Share Analysis, 2024 & 2030
- 10.2. Regional Market Dashboard
- 10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 10.4. North America
- 10.4.1. North America Sepsis Diagnostics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 10.4.2. U.S.
- 10.4.2.1. Key Country Dynamics
- 10.4.2.2. Regulatory Framework
- 10.4.2.3. Competitive Insights
- 10.4.2.4. U.S. Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.4.3. Canada
- 10.4.3.1. Key Country Dynamics
- 10.4.3.2. Regulatory Framework
- 10.4.3.3. Competitive Insights
- 10.4.3.4. Canada Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5. Europe
- 10.5.1. Europe Sepsis Diagnostics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 10.5.2. UK
- 10.5.2.1. Key Country Dynamics
- 10.5.2.2. Regulatory Framework
- 10.5.2.3. Competitive Insights
- 10.5.2.4. UK Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.3. Germany
- 10.5.3.1. Key Country Dynamics
- 10.5.3.2. Regulatory Framework
- 10.5.3.3. Competitive Insights
- 10.5.3.4. Germany Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.4. France
- 10.5.4.1. Key Country Dynamics
- 10.5.4.2. Regulatory Framework
- 10.5.4.3. Competitive Insights
- 10.5.4.4. France Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.5. Italy
- 10.5.5.1. Key Country Dynamics
- 10.5.5.2. Regulatory Framework
- 10.5.5.3. Competitive Insights
- 10.5.5.4. Italy Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.6. Spain
- 10.5.6.1. Key Country Dynamics
- 10.5.6.2. Regulatory Framework
- 10.5.6.3. Competitive Insights
- 10.5.6.4. Spain Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.7. Russia
- 10.5.7.1. Key Country Dynamics
- 10.5.7.2. Regulatory Framework
- 10.5.7.3. Competitive Insights
- 10.5.7.4. Russia Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.8. Norway
- 10.5.8.1. Key Country Dynamics
- 10.5.8.2. Regulatory Framework
- 10.5.8.3. Competitive Insights
- 10.5.8.4. Norway Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.9. Denmark
- 10.5.9.1. Key Country Dynamics
- 10.5.9.2. Regulatory Framework
- 10.5.9.3. Competitive Insights
- 10.5.9.4. Denmark Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.10. Sweden
- 10.5.10.1. Key Country Dynamics
- 10.5.10.2. Regulatory Framework
- 10.5.10.3. Competitive Insights
- 10.5.10.4. Sweden Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
- 11.1. Participant Overview
- 11.2. Company Market Position Analysis
- 11.3. Company Categorization
- 11.4. Strategy Mapping
- 11.5. Company Profiles/Listing
- 11.5.1. BD
- 11.5.1.1. Overview
- 11.5.1.2. Financial Performance
- 11.5.1.3. Product Benchmarking
- 11.5.1.4. Strategic Initiatives
- 11.5.2. bioMerieux SA
- 11.5.2.1. Overview
- 11.5.2.2. Financial Performance
- 11.5.2.3. Product Benchmarking
- 11.5.2.4. Strategic Initiatives
- 11.5.3. Thermo Fisher Scientific Inc.
- 11.5.3.1. Overview
- 11.5.3.2. Financial Performance
- 11.5.3.3. Product Benchmarking
- 11.5.3.4. Strategic Initiatives
- 11.5.4. Beckman Coulter, Inc. (Danaher Corporation)
- 11.5.4.1. Overview
- 11.5.4.2. Financial Performance
- 11.5.4.3. Product Benchmarking
- 11.5.4.4. Strategic Initiatives
- 11.5.5. F. Hoffmann-La Roche Ltd
- 11.5.5.1. Overview
- 11.5.5.2. Financial Performance
- 11.5.5.3. Product Benchmarking
- 11.5.5.4. Strategic Initiatives
- 11.5.6. Cepheid
- 11.5.6.1. Overview
- 11.5.6.2. Financial Performance
- 11.5.6.3. Product Benchmarking
- 11.5.6.4. Strategic Initiatives
- 11.5.7. Luminex Corp.
- 11.5.7.1. Overview
- 11.5.7.2. Financial Performance
- 11.5.7.3. Product Benchmarking
- 11.5.7.4. Strategic Initiatives
- 11.5.8. Koninklijke Philips N.V.
- 11.5.8.1. Overview
- 11.5.8.2. Financial Performance
- 11.5.8.3. Product Benchmarking
- 11.5.8.4. Strategic Initiatives
- 11.5.9. Bruker
- 11.5.9.1. Overview
- 11.5.9.2. Financial Performance
- 11.5.9.3. Product Benchmarking
- 11.5.9.4. Strategic Initiatives
- 11.5.10. Immunexpress Inc.
- 11.5.10.1. Overview
- 11.5.10.2. Financial Performance
- 11.5.10.3. Product Benchmarking
- 11.5.10.4. Strategic Initiatives
- 11.5.1. BD
Product Code: GVR-4-68040-511-8
List of Tables
- Table 1. List of secondary sources
- Table 2. List of abbreviations
- Table 3. North America and Europe sepsis diagnostics market, by region, 2018 - 2030 (USD Million)
- Table 4. North America and Europe sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 5. North America and Europe sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 6. North America and Europe sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 7. North America and Europe sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 8. North America and Europe sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 9. North America and Europe sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 10. North America sepsis diagnostics market, by country, 2018 - 2030 (USD Million)
- Table 11. North America sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 12. North America sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 13. North America sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 14. North America sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 15. North America sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 16. North America sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 17. U.S. sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 18. U.S. sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 19. U.S. sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 20. U.S. sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 21. U.S. sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 22. U.S. sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 23. Canada sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 24. Canada sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 25. Canada sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 26. Canada sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 27. Canada sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 28. Canada sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 29. Europe sepsis diagnostics market, by country, 2018 - 2030 (USD Million)
- Table 30. Europe sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 31. Europe sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 32. Europe sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 33. Europe sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 34. Europe sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 35. Europe sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 36. UK sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 37. UK sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 38. UK sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 39. UK sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 40. UK sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 41. UK sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 42. Germany sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 43. Germany sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 44. Germany sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 45. Germany sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 46. Germany sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 47. Germany sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 48. France sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 49. France sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 50. France sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 51. France sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 52. France sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 53. France sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 54. Italy sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 55. Italy sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 56. Italy sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 57. Italy sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 58. Italy sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 59. Italy sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 60. Spain sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 61. Spain sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 62. Spain sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 63. Spain sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 64. Spain sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 65. Spain sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 66. Russia sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 67. Russia sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 68. Russia sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 69. Russia sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 70. Russia sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 71. Russia sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 72. Denmark sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 73. Denmark sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 74. Denmark sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 75. Denmark sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 76. Denmark sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 77. Denmark sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 78. Sweden sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 79. Sweden sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 80. Sweden sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 81. Sweden sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 82. Sweden sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 83. Sweden sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
- Table 84. Norway sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 85. Norway sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
- Table 86. Norway sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
- Table 87. Norway sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
- Table 88. Norway sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
- Table 89. Norway sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 North America and Europe sepsis diagnostics market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 Market formulation & validation
- Fig. 8 Market snapshot
- Fig. 9 Product and technology outlook (USD Million)
- Fig. 10 Pathogen and testing outlook (USD Million)
- Fig. 11 Method and end use outlook (USD Million)
- Fig. 12 Competitive landscape
- Fig. 13 North America and Europe sepsis diagnostics market dynamics
- Fig. 14 North America and Europe sepsis diagnostics market: Porter's five forces analysis
- Fig. 15 North America and Europe sepsis diagnostics market: PESTLE analysis
- Fig. 16 North America and Europe sepsis diagnostics market: Product segment dashboard
- Fig. 17 North America and Europe sepsis diagnostics market: Product market share analysis, 2024 & 2030
- Fig. 18 Instruments market, 2018 - 2030 (USD Million)
- Fig. 19 Blood culture media market, 2018 - 2030 (USD Million)
- Fig. 20 Assay kits and reagents market, 2018 - 2030 (USD Million)
- Fig. 21 Software market, 2018 - 2030 (USD Million)
- Fig. 22 North America and Europe sepsis diagnostics market: Technology segment dashboard
- Fig. 23 North America and Europe sepsis diagnostics market: Technology market share analysis, 2024 & 2030
- Fig. 24 Microbiology market, 2018 - 2030 (USD Million)
- Fig. 25 Molecular diagnostics market, 2018 - 2030 (USD Million)
- Fig. 26 Polymerase chain reaction (PCR) market, 2018 - 2030 (USD Million)
- Fig. 27 DNA microarrays market, 2018 - 2030 (USD Million)
- Fig. 28 Syndromic panel testing market, 2018 - 2030 (USD Million)
- Fig. 29 Others market, 2018 - 2030 (USD Million)
- Fig. 30 Immunoassays market, 2018 - 2030 (USD Million)
- Fig. 31 Flow cytometry market, 2018 - 2030 (USD Million)
- Fig. 32 Others market, 2018 - 2030 (USD Million)
- Fig. 33 North America and Europe sepsis diagnostics market: Pathogen segment dashboard
- Fig. 34 North America and Europe sepsis diagnostics market: Pathogen market share analysis, 2024 & 2030
- Fig. 35 Bacterial sepsis market, 2018 - 2030 (USD Million)
- Fig. 36 Gram-positive bacteria market, 2018 - 2030 (USD Million)
- Fig. 37 Gram-negative bacteria market, 2018 - 2030 (USD Million)
- Fig. 38 Fungal sepsis market, 2018 - 2030 (USD Million)
- Fig. 39 Viral sepsis market, 2018 - 2030 (USD Million)
- Fig. 40 Others market, 2018 - 2030 (USD Million)
- Fig. 41 North America and Europe sepsis diagnostics market: Testing segment dashboard
- Fig. 42 North America and Europe sepsis diagnostics market: Testing market share analysis, 2024 & 2030
- Fig. 43 Laboratory testing market, 2018 - 2030 (USD Million)
- Fig. 44 PoC testing market, 2018 - 2030 (USD Million)
- Fig. 45 North America and Europe sepsis diagnostics market: Method segment dashboard
- Fig. 46 North America and Europe sepsis diagnostics market: Method market share analysis, 2024 & 2030
- Fig. 47 Automated diagnostics market, 2018 - 2030 (USD Million)
- Fig. 48 Conventional diagnostics market, 2018 - 2030 (USD Million)
- Fig. 49 North America and Europe sepsis diagnostics market: End use segment dashboard
- Fig. 50 North America and Europe sepsis diagnostics market: End use market share analysis, 2024 & 2030
- Fig. 51 Hospitals & clinics market, 2018 - 2030 (USD Million)
- Fig. 52 Pathology & reference laboratories market, 2018 - 2030 (USD Million)
- Fig. 53 Research institutes and others market, 2018 - 2030 (USD Million)
- Fig. 54 North America and Europe sepsis diagnostics market revenue, by region
- Fig. 55 Regional marketplace: Key takeaways
- Fig. 56 Regional marketplace: Key takeaways
- Fig. 57 North America sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 58 U.S. country dynamics
- Fig. 59 U.S. sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 60 Canada country dynamics
- Fig. 61 Canada sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 62 Europe sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 63 UK country dynamics
- Fig. 64 UK sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 65 Germany country dynamics
- Fig. 66 Germany sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 67 France country dynamics
- Fig. 68 France sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 69 Italy country dynamics
- Fig. 70 Italy sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 71 Spain country dynamics
- Fig. 72 Spain sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 73 Russia country dynamics
- Fig. 74 Russia sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 75 Norway country dynamics
- Fig. 76 Norway sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 77 Sweden country dynamics
- Fig. 78 Sweden sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 79 Denmark country dynamics
- Fig. 80 Denmark sepsis diagnostics market, 2018 - 2030 (USD Million)
- Fig. 81 Company categorization
- Fig. 82 Company market position analysis
- Fig. 83 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.